- 更多网络例句与乳腺癌相关的网络例句 [注：此内容来源于网络，仅供参考]
-
Annals of Internal Medicine ）,4 March 2008 | Volume 148 Issue 5 | Pages 337-347,Jeffrey A. Tice, Karla KerlikowskeJeffrey A. Tice, MD; Steven R. Cummings, MD; Rebecca Smith-Bindman, MD; Laura Ichikawa, MS; William E. Barlow, PhD; and Karla Kerlikowske, MD
美国旧金山加州大学Tice等报告，在乳腺癌预测模型中加入乳腺密度，能评估浸润性乳腺癌5年危险，但鉴别哪些女性将罹患乳腺癌时，该模型仅有中等准确性。
-
The LVI was found to be related to lymph metastasis, TNM stage (P.01) and ER status (P.05). Conclusion The results suggest the occurrence of lymphangiogenesis in breast cancer, microlymphatic vessel plays an important role in LVI, LVI ac tumor tissue may be useful in predicting lymph node metastasis in patients with breast cancer.
乳腺癌中存在淋巴管的生成，乳腺癌组织中的微淋巴管在介导LVI中起重要作用，LVI可能是乳腺癌淋巴结转移更有效的预测指标。
-
They say pollutants may be partly responsible for the rising incidence of breast cancer, up 90 percent in 50 years and triggered in lab studies by organochlorine pesticides, mercury, PAH and polyinyl chloride.
他们说化合物可能是引发乳腺癌发生率增加的部分原因。在过去50年乳腺癌增加了90％，实验室研究发现有机氯杀虫剂，水银，PAH和聚氯乙烯是引发乳腺癌的原因。
-
Any discussion of weight and breast cancer is a politically sensitive topic, for some may misconstrue that as the medical establishment blaming victims for getting breast cancer.
关于体重和乳腺癌之间关系的任何讨论都是一个政治敏感的话题，因为一些人可能会误解为，是医疗机构在责备乳腺癌受害者患上乳腺癌（即乳腺癌是女性自己引起的）。
-
Results(1)The frequency of BRCA1 mutation was 10% in 110 cases of Uigur and Han women with sporad...
结果(1)110例维吾尔族及汉族散发性乳腺癌中BRCA1的突变率为10%；其中70例维吾尔族散发性乳腺癌BRCA1的突变率为12.86%；新疆早发性乳腺癌(≤35岁)中BRCA1基因的突变率高于新疆晚发性乳腺癌，差异有统计学意义(χ2=9.429，P﹤0.01)。
-
Nm23, VEGF and ER can be used as markers in the prognostication of breast cancer. Patients with nm23, ER positive and VEGF negative have better postoperative prognosis. Expression of ER can be used as an early marker, Postmenopausal breast cancer patient should apply more active endocrinotherapy.
我们认为，乳腺癌的发生与癌组织中的 nln23、pZI VEGF和 ER过度表达有密切相关，nln23阳性、VEGF阴性和 ER 阳性的乳腺癌术后预后较好，癌组织中的m23、VE GF和ER表达可以作为判断乳腺癌预后的指标；ER的表达可以作为乳腺癌的早期标记物；绝经后乳腺癌病人应采取更积极的内分泌治疗。
-
Cent of patient of 51 breast cancer is the method two groups, use medical group of biology albumen rubber 25 routine breast cancer is improved effect a radical cure glue of use biology albumen is achieved in the operation when art, did not use medical group of biology albumen rubber 26 routine breast cancer is improved effect a radical cure biology albumen gum is not used when art, the 1st day drainage after observing art always makes the discharge, hypodermic case that accumulate fluid after quantity, art, in order to decide medical biology albumen glue is improved to breast cancer the precautionary effect that effects a radical cure fluid is accumulated hypodermically after art.
方法51例乳腺癌患者分为两组，采用医用生物蛋白胶组25例行乳腺癌改良根治术时在手术创面使用生物蛋白胶，未用医用生物蛋白胶组26例行乳腺癌改良根治术时不使用生物蛋白胶，观察术后第1天引流量、术后总引流量、皮下积液情况，以确定医用生物蛋白胶对乳腺癌改良根治术后皮下积液的预防效果。
-
All the LOH on 〓 and 〓 was observed in invasive ductal carcino- ma, carcinoma simplex, medulary carcinoma and scirrhous carcino- ma, no deletions at these sites were observed in any invasive lobular carcinoma and others. These results imply an etiological difference.P53 gene is a hot point gene in the occurrence and development of breast, cancer. PCR-SSCP analysis was performed to detect P53 gene point mutation in the region between exon 5 and 8, 5 of 12 (41. 6%) stage I breast cancer patients contain mutation of P53, 3 of 5 patients were accompanied by 〓 deletion. These results suggested that point mutation and allelic loss of P53 gene are two vi- tal genetic events in earlier stage of breast tumorigenesis.
我们还发现，〓和〓位点LOH均分布在乳腺浸润性导管癌、单纯癌、髓样癌及硬癌中，在浸润性小叶癌和某些特殊类型乳腺癌中全部为LOH阴性，上述位点LOH可能与某些组织学类型乳腺癌的发生有关。P53基因是乳腺癌形成过程中的一个热点基因，本研究对12例Ⅰ期乳腺癌组织标本中P53基因热点区域第5、6、7、8外显子点突变进行了测定，发现41.6％（5／12）的病人有P53基因一个或多个点突变，其中3例同时伴有〓位点LOH，表明P53基因点突变和等位基因缺失是发生在乳腺癌形成早期的一个重要遗传学事件。
-
Begg argues that all risk factors for breast cancer are overrepresented in incident cases of breast cancer, so that a sample of women who have been diagnosed with breast cancer and who are identified as mutation carriers are more likely to have other breast cancer risk factors than similar mutation carriers who are disease-free.
Dr。 Begg认为，所有的乳腺癌危险因子在乳腺癌病例中都被高估，所以一些已经被诊断为乳腺癌，且确认是某种基因突变的携带者妇女，比起具有相似的遗传突变的健康携带者，更可能是其他乳腺癌的危险因子导致疾病发生。
-
Begg argues that all risk factors for breast cancer are overrepresented in incident cases of breast cancer, so that a sample of women who have been diagnosed with breast cancer and who are identified as mutation carriers are more likely to have other breast cancer risk factors than similar mutation carriers who are disease-free.
Dr。 Begg认为，所有的乳腺癌危险因子在乳腺癌病例中都被高估，所以一些已经被诊断为乳腺癌，且确认是某种基因突变的携带者妇女，比起具有相似的遗传突变的健康携带者，更可能是其它乳腺癌的危险因子导致疾病发生。
- 更多网络解释与乳腺癌相关的网络解释 [注：此内容来源于网络，仅供参考]
-
breast cancer：乳腺癌
比如可以搜索到"乳腺癌"(breast cancer)却没法直接搜索到"乳房"(breast),Zoo.com 目的也就是可以让父母们脱离监控环境(软硬件). 不过现在的孩子都是越来越聪明的,是不是真会有效呢?
-
familial breast cancer：家族性乳腺癌
家族性卵巢癌:familial ovarian cancer | 家族性乳腺癌:familial breast cancer | 家族性热性惊厥:familial febrile seizures
-
Inflammatory breast cancer：炎性乳腺癌
59. 卵巢癌Ovarian cancer | 60. 炎性乳腺癌Inflammatory breast cancer | 61. 膀胱过度活动症Overactive bladder syndrome
-
One front breast pocket：一前乳腺癌的口袋
Features: 特点: | One front breast pocket一前乳腺癌的口袋 | Ties in front关系在前线
-
Deng, Chuxia：邓初夏 国立健康研究院 在老鼠进行的遗传分析推动我们对乳腺癌机理的理解
Chow, Louise Tsi周芷 阿拉巴马大学 内含子和RNA剪接的最... | Deng, Chuxia邓初夏 国立健康研究院 在老鼠进行的遗传分析推动我们对乳腺癌机理的理解 | Dong, Xinnian董新年 杜克大学 植物防御微生物病原体的机理,系统...
-
Deng, Chuxia：邓初夏 国立健康研究院 在老鼠进行的遗传分析推动我们对乳腺癌机理的理
Chow, Louise Tsi周芷 阿拉巴马大学 内含子和RNA剪接的最早... | Deng, Chuxia邓初夏 国立健康研究院 在老鼠进行的遗传分析推动我们对乳腺癌机理的理 | Dong, Xinnian董新年 杜克大学 植物防御微生物病原体的机理,系统...
-
Paik NamSun：韩国国立癌症研究院外科教授, 韩国乳腺癌协会前任会长
tadashi ikeda,日本东京东海大学医院教授, 现任日本乳腺癌协会会长 | tomoo tajima,日本乳腺癌协会前任会长 | paik namsun,韩国国立癌症研究院外科教授, 韩国乳腺癌协会前任会长
-
Buserelin Ph. Eur：布舍瑞林 (欧洲药典) 乳腺癌、前列腺癌激素治疗
Antide Acetate 安替肽 乳腺癌、前列腺癌激素治疗 | Buserelin Ph. Eur 布舍瑞林 (欧洲药典) 乳腺癌、前列腺癌激素治疗 | Deslorelin Acetate 德舍瑞林 乳腺癌、前列腺癌激素治疗
-
Goserelin Acetate Ph. Eur：戈舍瑞林 (欧洲药典) 乳腺癌、前列腺癌激素治疗
Gonadorelin Acetate Ph. Eur. 醋酸戈那瑞林(欧洲药典) 乳腺癌、前列腺癌激素治疗 | Goserelin Acetate Ph. Eur 戈舍瑞林 (欧洲药典) 乳腺癌、前列腺癌激素治疗 | Histrelin Acetate 组氨瑞林 乳腺癌、前列腺癌激素治疗
-
Leuprolide Acetate Ph. Eur：亮丙瑞林(欧洲药典) 乳腺癌、前列腺癌激素治疗
Histrelin Acetate 组氨瑞林 乳腺癌、前列腺癌激素治疗 | Leuprolide Acetate Ph. Eur. 亮丙瑞林(欧洲药典) 乳腺癌、前列腺癌激素治疗 | Nafarelin Acetate 那法瑞林 乳腺癌、前列腺癌激素治疗